Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine.

Leiting JL, Murphy SJ, Bergquist JR, Hernandez MC, Ivanics T, Abdelrahman AM, Yang L, Lynch I, Smadbeck JB, Cleary SP, Nagorney DM, Torbenson MS, Graham RP, Roberts LR, Gores GJ, Smoot RL, Truty MJ.

JHEP Rep. 2020 Jan 16;2(2):100068. doi: 10.1016/j.jhepr.2020.100068. eCollection 2020 Apr.

2.

Intestinal Spirochetosis.

Erickson LA, Torbenson MS.

Mayo Clin Proc. 2020 Feb;95(2):427-428. doi: 10.1016/j.mayocp.2019.12.003. No abstract available.

PMID:
32029097
3.

Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.

Singhi AD, Wood LD, Parks E, Torbenson MS, Felsenstein M, Hruban RH, Nikiforova MN, Wald AI, Kaya C, Nikiforov YE, Favazza L, He J, McGrath K, Fasanella KE, Brand RE, Lennon AM, Furlan A, Dasyam AK, Zureikat AH, Zeh HJ, Lee K, Bartlett DL, Slivka A.

Gastroenterology. 2020 Feb;158(3):573-582.e2. doi: 10.1053/j.gastro.2019.10.028. Epub 2019 Oct 31.

4.

The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension.

Navin PJ, Gidener T, Allen AM, Yin M, Takahashi N, Torbenson MS, Kamath PS, Ehman RL, Venkatesh SK.

Clin Gastroenterol Hepatol. 2019 Oct 17. pii: S1542-3565(19)31162-0. doi: 10.1016/j.cgh.2019.10.018. [Epub ahead of print]

PMID:
31629882
5.

Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials.

Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V.

Aliment Pharmacol Ther. 2019 Nov;50(10):1100-1111. doi: 10.1111/apt.15503. Epub 2019 Oct 3.

PMID:
31583739
6.

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis.

Venkatesh SK, Hoodeshenas S, Venkatesh SH, Dispenzieri A, Gertz MA, Torbenson MS, Ehman RL.

J Clin Med. 2019 May 23;8(5). pii: E739. doi: 10.3390/jcm8050739.

7.

Anastomosing hemangioma of the liver: a case series.

Lunn B, Yasir S, Lam-Himlin D, Menias CO, Torbenson MS, Venkatesh SK.

Abdom Radiol (NY). 2019 Aug;44(8):2781-2787. doi: 10.1007/s00261-019-02043-x.

PMID:
31069477
8.

Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns.

Yasir S, Torbenson MS.

Am J Surg Pathol. 2019 May;43(5):581-590. doi: 10.1097/PAS.0000000000001228.

PMID:
30986799
9.

Identification of key challenges in liver pathology: data from a multicenter study of extramural consults.

Torbenson MS, Arnold CA, Graham RP, Jain D, Kakar S, Lam-Himlin DM, Naini BV, Wu TT, Yeh M.

Hum Pathol. 2019 May;87:75-82. doi: 10.1016/j.humpath.2019.03.001. Epub 2019 Mar 8.

PMID:
30857968
10.

Knowledge gaps in the appendix: a multi-institutional study from seven academic centers.

Arnold CA, Graham RP, Jain D, Kakar S, Lam-Himlin DM, Naini BV, Wu TT, Yeh MM, Torbenson MS.

Mod Pathol. 2019 Jul;32(7):988-996. doi: 10.1038/s41379-019-0216-x. Epub 2019 Feb 14.

PMID:
30765881
11.

Hamartomas and malformations of the liver.

Torbenson MS.

Semin Diagn Pathol. 2019 Jan;36(1):39-47. doi: 10.1053/j.semdp.2018.11.005. Epub 2018 Nov 17. Review.

PMID:
30579648
12.

The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis.

Navin PJ, Hilscher MB, Welle CL, Mounajjed T, Torbenson MS, Kamath PS, Venkatesh SK.

Hepatology. 2019 Jan;69(1):452-454. doi: 10.1002/hep.30175. Epub 2018 Dec 25. No abstract available.

PMID:
30014488
13.

Co-expression of CDX2 and CK20 in hepatocellular carcinoma, an exceedingly rare co-incidence with potential diagnostic pitfall-reply.

Chandan VS, Shah SS, Torbenson MS, Wu TT.

Hum Pathol. 2018 Nov;81:299. doi: 10.1016/j.humpath.2018.04.030. Epub 2018 Jul 4. No abstract available.

PMID:
29981308
14.

Colonic Adenomatous Polyps Involving Submucosal Lymphoglandular Complexes: A Diagnostic Pitfall.

Lee HE, Wu TT, Chandan VS, Torbenson MS, Mounajjed T.

Am J Surg Pathol. 2018 Aug;42(8):1083-1089. doi: 10.1097/PAS.0000000000001081.

PMID:
29738362
15.

Desmoid Tumor.

Nath MC, Torbenson MS, Erickson LA.

Mayo Clin Proc. 2018 Apr;93(4):549-550. doi: 10.1016/j.mayocp.2018.02.009. No abstract available.

PMID:
29622108
16.

Perihilar Cholangiocarcinoma.

Nath MC, Torbenson MS, Erickson LA.

Mayo Clin Proc. 2018 Mar;93(3):397-398. doi: 10.1016/j.mayocp.2018.01.017. No abstract available.

PMID:
29502573
17.

Treponema pallidum Immunohistochemistry is positive in human intestinal Spirochetosis.

Graham RP, Naini BV, Shah SS, Arnold CA, Kannangai R, Torbenson MS, Lam-Himlin DM.

Diagn Pathol. 2018 Jan 22;13(1):7. doi: 10.1186/s13000-017-0676-6.

18.

Intracranial metastasis in fibrolamellar hepatocellular carcinoma.

Hammond WJ, Lalazar G, Saltsman JA, Farber BA, Danzer E, Sherpa TC, Banda CD, Andolina JR, Karimi S, Brennan CW, Torbenson MS, La Quaglia MP, Simon SM.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26919. Epub 2017 Dec 29.

19.

Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.

Graham RP, Lackner C, Terracciano L, González-Cantú Y, Maleszewski JJ, Greipp PT, Simon SM, Torbenson MS.

Hepatology. 2018 Oct;68(4):1441-1447. doi: 10.1002/hep.29719. Epub 2018 May 11.

20.

Hepatic tumors of vascular origin: imaging appearances.

Ehman EC, Torbenson MS, Wells ML, Welch BT, Thompson SM, Garg I, Venkatesh SK.

Abdom Radiol (NY). 2018 Aug;43(8):1978-1990. doi: 10.1007/s00261-017-1401-3. Review.

PMID:
29159525
21.

Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma.

Chandan VS, Shah SS, Mounajjed T, Torbenson MS, Wu TT.

J Clin Pathol. 2018 Jun;71(6):504-507. doi: 10.1136/jclinpath-2017-204820. Epub 2017 Nov 10.

PMID:
29127141
22.

A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.

Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V.

Hum Pathol. 2017 Nov;69:90-95. doi: 10.1016/j.humpath.2017.09.007. Epub 2017 Sep 29.

PMID:
28970136
23.

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.

Graham RP, Yeh MM, Lam-Himlin D, Roberts LR, Terracciano L, Cruise MW, Greipp PT, Zreik RT, Jain D, Zaid N, Salaria SN, Jin L, Wang X, Rustin JG, Kerr SE, Sukov WR, Solomon DA, Kakar S, Waterhouse E, Gill RM, Ferrell L, Alves VA, Nart D, Yilmaz F, Roessler S, Longerich T, Schirmacher P, Torbenson MS.

Mod Pathol. 2018 Jan;31(1):141-149. doi: 10.1038/modpathol.2017.103. Epub 2017 Sep 1.

24.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ; Cancer Genome Atlas Network, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN.

Cell Rep. 2017 Jun 27;19(13):2878-2880. doi: 10.1016/j.celrep.2017.06.008. No abstract available.

25.

Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH.

Abdom Radiol (NY). 2017 Aug;42(8):2037-2053. doi: 10.1007/s00261-017-1211-7. Review.

26.

The Almost-Normal Liver Biopsy: Presentation, Clinical Associations, and Outcome.

Czeczok TW, Van Arnam JS, Wood LD, Torbenson MS, Mounajjed T.

Am J Surg Pathol. 2017 Sep;41(9):1247-1253. doi: 10.1097/PAS.0000000000000881.

PMID:
28614198
27.

Morphologic Subtypes of Hepatocellular Carcinoma.

Torbenson MS.

Gastroenterol Clin North Am. 2017 Jun;46(2):365-391. doi: 10.1016/j.gtc.2017.01.009. Review.

PMID:
28506370
28.

Hepatic segmental atrophy and nodular elastosis: imaging features.

Garg I, Graham RP, VanBuren WM, Goenka AH, Torbenson MS, Venkatesh SK.

Abdom Radiol (NY). 2017 Oct;42(10):2447-2453. doi: 10.1007/s00261-017-1164-x.

PMID:
28456818
29.

Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.

Dinh TA, Vitucci EC, Wauthier E, Graham RP, Pitman WA, Oikawa T, Chen M, Silva GO, Greene KG, Torbenson MS, Reid LM, Sethupathy P.

Sci Rep. 2017 Mar 17;7:44653. doi: 10.1038/srep44653.

30.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ; Cancer Genome Atlas Network, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN.

Cell Rep. 2017 Mar 14;18(11):2780-2794. doi: 10.1016/j.celrep.2017.02.033. Erratum in: Cell Rep. 2017 Jun 27;19(13):2878-2880.

31.

Environmental exposures as a risk factor for fibrolamellar carcinoma.

Graham RP, Craig JR, Jin L, Oliveira AM, Bergquist JR, Truty MJ, Mounajjed T, Greipp PT, Torbenson MS.

Mod Pathol. 2017 Jun;30(6):892-896. doi: 10.1038/modpathol.2017.7. Epub 2017 Mar 3.

32.

Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet.

Mahadev S, Murray JA, Wu TT, Chandan VS, Torbenson MS, Kelly CP, Maki M, Green PH, Adelman D, Lebwohl B.

Aliment Pharmacol Ther. 2017 Apr;45(8):1084-1093. doi: 10.1111/apt.13988. Epub 2017 Feb 20.

33.

Immunohistochemistry and Special Stains in Medical Liver Pathology.

Clark I, Torbenson MS.

Adv Anat Pathol. 2017 Mar;24(2):99-109. doi: 10.1097/PAP.0000000000000139. Review.

PMID:
28181953
34.

Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings.

Graham RP, Torbenson MS.

Semin Diagn Pathol. 2017 Mar;34(2):146-152. doi: 10.1053/j.semdp.2016.12.010. Epub 2016 Dec 23. Review.

PMID:
28110996
35.

Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall.

Shah SS, Wu TT, Torbenson MS, Chandan VS.

Hum Pathol. 2017 Jun;64:13-18. doi: 10.1016/j.humpath.2016.12.029. Epub 2017 Jan 13.

PMID:
28089540
36.

Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy.

Mukewar S, Sharma A, Lackore KA, Enders FT, Torbenson MS, Kamath PS, Roberts LR, Kudva YC.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):927-933. doi: 10.1016/j.cgh.2016.11.038. Epub 2016 Dec 30.

PMID:
28043933
37.

Khat chewing and cirrhosis in Somaliland: Case series.

Mahamoud HD, Muse SM, Roberts LR, Fischer PR, Torbenson MS, Fader T.

Afr J Prim Health Care Fam Med. 2016 Jul 28;8(1):e1-4. doi: 10.4102/phcfm.v8i1.1124.

38.

Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases.

Fritchie KJ, Jin L, Wang X, Graham RP, Torbenson MS, Lewis JE, Rivera M, Garcia JJ, Schembri-Wismayer DJ, Westendorf JJ, Chou MM, Dong J, Oliveira AM.

Histopathology. 2016 Dec;69(6):930-936. doi: 10.1111/his.13045. Epub 2016 Sep 23.

PMID:
27454570
39.

Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.

Blackburn PR, Hickey RD, Nace RA, Giama NH, Kraft DL, Bordner AJ, Chaiteerakij R, McCormick JB, Radulovic M, Graham RP, Torbenson MS, Tortorelli S, Scott CR, Lindor NM, Milliner DS, Oglesbee D, Al-Qabandi W, Grompe M, Gavrilov DK, El-Youssef M, Clark KJ, Atwal PS, Roberts LR, Klee EW, Ekker SC.

Hum Mutat. 2016 Oct;37(10):1097-105. doi: 10.1002/humu.23047. Epub 2016 Aug 8.

40.

Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant.

Young JT, Kurup AN, Graham RP, Torbenson MS, Venkatesh SK.

Abdom Radiol (NY). 2016 Nov;41(11):2115-2122.

PMID:
27334021
41.

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.

Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR.

Cancer Lett. 2016 Sep 28;380(1):163-73. doi: 10.1016/j.canlet.2016.05.017. Epub 2016 May 20.

42.

Erratum to "Clinical implications of basic research in hepatocellular carcinoma" [J Hepatol 2016;64:736-745].

Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR.

J Hepatol. 2016 Jun;64(6):1462. doi: 10.1016/j.jhep.2016.02.036. Epub 2016 Mar 22. No abstract available.

PMID:
27198051
43.

Arginase-1 is frequently positive in hepatoid adenocarcinomas.

Chandan VS, Shah SS, Torbenson MS, Wu TT.

Hum Pathol. 2016 Sep;55:11-6. doi: 10.1016/j.humpath.2016.04.008. Epub 2016 Apr 30.

PMID:
27137985
44.

Man With Fever and Severe Diarrhea.

Lehrke HD, Torbenson MS, Erickson LA.

Mayo Clin Proc. 2016 Apr;91(4):e55-6. doi: 10.1016/j.mayocp.2016.01.021. No abstract available.

PMID:
27046533
45.

Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.

Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW.

Mod Pathol. 2016 Jun;29(6):607-15. doi: 10.1038/modpathol.2016.59. Epub 2016 Mar 25.

46.

Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue.

Schafer MJ, White TA, Evans G, Tonne JM, Verzosa GC, Stout MB, Mazula DL, Palmer AK, Baker DJ, Jensen MD, Torbenson MS, Miller JD, Ikeda Y, Tchkonia T, van Deursen JM, Kirkland JL, LeBrasseur NK.

Diabetes. 2016 Jun;65(6):1606-15. doi: 10.2337/db15-0291. Epub 2016 Mar 16.

47.

Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas.

Liu L, Shah SS, Naini BV, French S, Wu TT, Torbenson MS, Chandan VS.

Am J Surg Pathol. 2016 Aug;40(8):1062-9. doi: 10.1097/PAS.0000000000000624.

PMID:
26927891
48.

Hepatocellular Neoplasms Arising in Association With Androgen Use.

Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T.

Am J Surg Pathol. 2016 Apr;40(4):454-61. doi: 10.1097/PAS.0000000000000576.

PMID:
26685086
49.

Clinical implications of basic research in hepatocellular carcinoma.

Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR.

J Hepatol. 2016 Mar;64(3):736-45. doi: 10.1016/j.jhep.2015.09.008. Epub 2015 Oct 9. Review.

50.

FGFR1 and FGFR2 in fibrolamellar carcinoma.

Graham RP, Garcia JJ, Greipp PT, Barr Fritcher EG, Kipp BR, Torbenson MS.

Histopathology. 2016 Apr;68(5):686-92. doi: 10.1111/his.12799. Epub 2015 Oct 5.

PMID:
26259677

Supplemental Content

Loading ...
Support Center